Consumer Defensive
Glanbia plc(GLAPY)
Live Price
Offline$122.58
-4.35% today
1Y Change
+80.49%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $5.61B
- Revenue Growth
- +3.0%
- EPS Growth
- +17.7%
- Dividend Yield
- 2.2%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Glanbia plc (GLAPY) is a Consumer Defensive stock with a market cap of $5.61B and listed on OTC. The stock last traded around $122.58 and up 80.5% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +3.0%, EPS growth of +17.7%, a dividend yield of 2.2%. What stands out right now is revenue +3.0%, EPS +17.7%, free cash flow -6.7% with operating margin 8.0% and ROIC 8.2%. The dividend is present but secondary, with a yield around 2.2%. Valuation already assumes a fairly strong business story at P/E 33.5 and price/sales 1.5. Stock Foundry combines GLAPY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+3.0% vs +1.7% peer median
Operating Margin
Near sector median
+8.0% vs +6.6% peer median
P/E
Above sector median
33.5 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on Feb 25, 2026 with an EPS surprise of +3.5% and a revenue surprise of +3.4%.
The operating story is still moving forward
Revenue is running at +3.0% and EPS at +17.7%, with operating margin around 8.0%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 6, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 25, 2026 | +3.5% | +0.0% | +0.0% | +0.0% |
2025 Feb 26, 2025 | -96.5% | +0.0% | +0.0% | +0.0% |
2024 Nov 6, 2024 | -83.8% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
GLAPY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GLAPY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GLAPY Max Drawdown
-5.51%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for GLAPY and SPY.
Company Overview
Glanbia plc
Other OTC
Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
- Leadership
- Hugh McGuire Finance
- IPO Date
- Oct 17, 2012
- Employees
- 5.8k
- Street Address
- Glanbia House
- Mailing
- Kilkenny, R95 E866
- Region
- Kilkenny, IE
- Reporting Currency
- USD
- Investor Line
- 353 56 777 2200
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 33.5
- EV/EBITDA
- 13.8
- Price/Sales
- 1.5
- Price/Book
- 2.9
Growth
- Revenue
- +3.0%
- EPS
- +17.7%
- Free Cash Flow
- -6.7%
Profitability
- Gross Margin
- 25.9%
- Operating Margin
- 8.0%
- Net Margin
- 4.6%
- ROE
- 9.2%
- ROIC
- 8.2%
Balance Sheet
- Debt/Equity
- 0.63
- Current Ratio
- 1.36
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.